Conv. Plasma
Nigella Sativa

All curcumin studies
Meta analysis
study COVID-19 treatment researchCurcuminCurcumin (more..)
Melatonin Meta
Metformin Meta
Azvudine Meta
Bromhexine Meta Molnupiravir Meta
Budesonide Meta
Colchicine Meta
Conv. Plasma Meta Nigella Sativa Meta
Curcumin Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   

Throat spray formulated with virucidal Pharmaceutical excipients as an effective early prophylactic or treatment strategy against pharyngitis post-exposure to SARS CoV-2

Boseila et al., European Journal of Pharmaceutics and Biopharmaceutics, doi:10.1016/j.ejpb.2024.114279
Apr 2024  
  Source   PDF   All Studies   Meta AnalysisMeta
Curcumin for COVID-19
14th treatment shown to reduce risk in February 2021
*, now known with p = 0.000000046 from 26 studies.
No treatment is 100% effective. Protocols combine complementary and synergistic treatments. * >10% efficacy in meta analysis with ≥3 clinical studies.
4,100+ studies for 60+ treatments.
In Silico, In Vitro, and rat study showing potential prophylactic and therapeutic benefits of a curcumin-loaded self-nanoemulsifying drug delivery system throat spray against SARS-CoV-2 infection and pharyngitis. Molecular docking studies identified DEAE-Dx, curcumin, trans-anethole, Tween 80, and PEG400 as top candidates for the spray formulation, based on binding to SARS-CoV-2 spike and main protease (Mpro) targets. The optimal formula, containing 0.1% curcumin, demonstrated anti-SARS-CoV-2 activity in vitro. In a rat model of acute pharyngitis, post-treatment with the curcumin spray significantly reduced proinflammatory markers TNF-α, IL-6, MCP-1, and IL-8. Preclinical toxicity tests in male rats confirmed the safety of the throat spray at a 5 µg/mL curcumin dose.
In Silico studies predict inhibition of SARS-CoV-2 with curcumin or metabolites via binding to the spike Note A, Nag, Moschovou, Kandeil, Singh (B), Boseila (and specifically the receptor binding domain Note B, Kant, Srivastava, Eleraky), Mpro Note C, Moschovou, Kandeil, Srivastava, Naderi Beni, Rajagopal, Rampogu, Sekiou, Singh, Winih Kinasih, Thapa, Bahun, Eleraky, Boseila, RNA-dependent RNA polymerase Note D, Singh (C), Eleraky, ACE2 Note E, Singh (B), Thapa, Alkafaas, nucleocapsid Note F, Hidayah, Suravajhala, and nsp10 Note G, Suravajhala proteins. In Vitro studies demonstrate inhibition of the spike Note A, Mohd Abd Razak (and specifically the receptor binding domain Note B, Goc (B)), Mpro Note C, Bahun, Guijarro-Real, Mohd Abd Razak, Wu, ACE2 Note E, Goc (B), and TMPRSS2 Note H, Goc (B) proteins. In Vitro studies demonstrate efficacy in Calu-3 Note I, Bormann, A549 Note J, Mohd Abd Razak, 293T Note K, Zhang, HEK293-hACE2 Note L, Nittayananta, Wu, 293T/hACE2/TMPRSS2 Note M, Septisetyani, Vero E6 Note N, Bormann, Eleraky, Kandeil, Leka, Mohd Abd Razak, Nittayananta, Singh, Teshima, Marín-Palma, and SH-SY5Y Note O, Nicoliche cells. Curcumin is predicted to inhibit the interaction between the SARS-CoV-2 spike protein receptor binding domain and the human ACE2 receptor for the delta and omicron variants Kant, decreases pro-inflammatory cytokines induced by SARS-CoV-2 in peripheral blood mononuclear cells Marín-Palma, and alleviates SARS-CoV-2 spike protein-induced mitochondrial membrane damage and oxidative stress Zhang.
Boseila et al., 7 Apr 2024, peer-reviewed, 7 authors.
This PaperCurcuminAll
{ 'DOI': '10.1016/j.ejpb.2024.114279', 'ISSN': ['0939-6411'], 'URL': '', 'alternative-id': ['S093964112400105X'], 'article-number': '114279', 'assertion': [ {'label': 'This article is maintained by', 'name': 'publisher', 'value': 'Elsevier'}, { 'label': 'Article Title', 'name': 'articletitle', 'value': 'Throat spray formulated with virucidal Pharmaceutical excipients as an ' 'effective early prophylactic or treatment strategy against pharyngitis ' 'post-exposure to SARS CoV-2'}, { 'label': 'Journal Title', 'name': 'journaltitle', 'value': 'European Journal of Pharmaceutics and Biopharmaceutics'}, { 'label': 'CrossRef DOI link to publisher maintained version', 'name': 'articlelink', 'value': ''}, {'label': 'Content Type', 'name': 'content_type', 'value': 'article'}, { 'label': 'Copyright', 'name': 'copyright', 'value': '© 2024 Elsevier B.V. All rights reserved.'}], 'author': [ {'affiliation': [], 'family': 'Boseila', 'given': 'Amira A.', 'sequence': 'first'}, {'affiliation': [], 'family': 'Ghareeb', 'given': 'Ahmed Z.', 'sequence': 'additional'}, {'affiliation': [], 'family': 'AbdElwahab', 'given': 'Miral G.', 'sequence': 'additional'}, {'affiliation': [], 'family': 'Seadawy', 'given': 'Mohamed G.', 'sequence': 'additional'}, {'affiliation': [], 'family': 'Al-Karmalawy', 'given': 'Ahmed A.', 'sequence': 'additional'}, {'affiliation': [], 'family': 'Yassa', 'given': 'Nashwa W.', 'sequence': 'additional'}, {'affiliation': [], 'family': 'Ghareeb', 'given': 'Doaa A.', 'sequence': 'additional'}], 'container-title': 'European Journal of Pharmaceutics and Biopharmaceutics', 'container-title-short': 'European Journal of Pharmaceutics and Biopharmaceutics', 'content-domain': {'crossmark-restriction': True, 'domain': ['', '']}, 'created': {'date-parts': [[2024, 4, 7]], 'date-time': '2024-04-07T07:38:20Z', 'timestamp': 1712475500000}, 'deposited': { 'date-parts': [[2024, 4, 7]], 'date-time': '2024-04-07T07:38:35Z', 'timestamp': 1712475515000}, 'funder': [ { 'DOI': '10.13039/100022922', 'doi-asserted-by': 'publisher', 'name': 'Misr El Kheir Foundation'}], 'indexed': {'date-parts': [[2024, 4, 8]], 'date-time': '2024-04-08T00:33:48Z', 'timestamp': 1712536428325}, 'is-referenced-by-count': 0, 'issued': {'date-parts': [[2024, 4]]}, 'language': 'en', 'license': [ { 'URL': '', 'content-version': 'tdm', 'delay-in-days': 0, 'start': { 'date-parts': [[2024, 4, 1]], 'date-time': '2024-04-01T00:00:00Z', 'timestamp': 1711929600000}}, { 'URL': '', 'content-version': 'stm-asf', 'delay-in-days': 0, 'start': { 'date-parts': [[2024, 4, 1]], 'date-time': '2024-04-01T00:00:00Z', 'timestamp': 1711929600000}}, { 'URL': '', 'content-version': 'stm-asf', 'delay-in-days': 0, 'start': { 'date-parts': [[2024, 4, 1]], 'date-time': '2024-04-01T00:00:00Z', 'timestamp': 1711929600000}}, { 'URL': '', 'content-version': 'stm-asf', 'delay-in-days': 0, 'start': { 'date-parts': [[2024, 4, 1]], 'date-time': '2024-04-01T00:00:00Z', 'timestamp': 1711929600000}}, { 'URL': '', 'content-version': 'stm-asf', 'delay-in-days': 0, 'start': { 'date-parts': [[2024, 4, 1]], 'date-time': '2024-04-01T00:00:00Z', 'timestamp': 1711929600000}}, { 'URL': '', 'content-version': 'stm-asf', 'delay-in-days': 0, 'start': { 'date-parts': [[2024, 4, 1]], 'date-time': '2024-04-01T00:00:00Z', 'timestamp': 1711929600000}}], 'link': [ { 'URL': '', 'content-type': 'text/xml', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': '', 'content-type': 'text/plain', 'content-version': 'vor', 'intended-application': 'text-mining'}], 'member': '78', 'original-title': [], 'page': '114279', 'prefix': '10.1016', 'published': {'date-parts': [[2024, 4]]}, 'published-print': {'date-parts': [[2024, 4]]}, 'publisher': 'Elsevier BV', 'reference': [ { 'DOI': '10.1016/j.biocel.2008.06.010', 'article-title': 'Potential therapeutic effects of curcumin, the anti-inflammatory agent, ' 'against neurodegenerative, cardiovascular, pulmonary, metabolic, ' 'autoimmune and neoplastic diseases', 'author': 'Aggarwal', 'doi-asserted-by': 'crossref', 'first-page': '40', 'issue': '1', 'journal-title': 'Int J Biochem Cell Biol.', 'key': '10.1016/j.ejpb.2024.114279_b0005', 'volume': '41', 'year': '2009'}, { 'DOI': '10.3390/nano8090634', 'article-title': 'Health concerns of various nanoparticles: A review of their in vitro ' 'and in vivo toxicity', 'author': 'Ajdary', 'doi-asserted-by': 'crossref', 'first-page': '634', 'issue': '9', 'journal-title': 'Nanomaterials', 'key': '10.1016/j.ejpb.2024.114279_b0010', 'volume': '8', 'year': '2018'}, { 'DOI': '10.1016/S0023-6438(95)80008-5', 'article-title': 'Use of a free radical method to evaluate antioxidant activity', 'author': 'Brand-Williams', 'doi-asserted-by': 'crossref', 'first-page': '25', 'issue': '1', 'journal-title': 'LWT-Food Science and Technology', 'key': '10.1016/j.ejpb.2024.114279_b0015', 'volume': '28', 'year': '1995'}, { 'DOI': '10.3390/pharmaceutics12121194', 'article-title': 'Self-nano-emulsifying drug-delivery systems: From the development to ' 'the current applications and challenges in oral drug delivery', 'author': 'Buya', 'doi-asserted-by': 'crossref', 'first-page': '1194', 'issue': '12', 'journal-title': 'Pharmaceutics', 'key': '10.1016/j.ejpb.2024.114279_b0020', 'volume': '12', 'year': '2020'}, { 'DOI': '10.3390/plants10122626', 'article-title': 'Phytochemical characterization and evaluation of biological activities ' 'of egyptian carob pods (Ceratonia siliqua L.) aqueous extract: In vitro ' 'study', 'author': 'Darwish', 'doi-asserted-by': 'crossref', 'first-page': '2626', 'issue': '12', 'journal-title': 'Plants', 'key': '10.1016/j.ejpb.2024.114279_b0025', 'volume': '10', 'year': '2021'}, { 'DOI': '10.2217/nnm.11.38', 'article-title': 'Lecithin-based novel cationic nanocarriers (LeciPlex) I: fabrication, ' 'characterization and evaluation', 'author': 'Date', 'doi-asserted-by': 'crossref', 'first-page': '1309', 'issue': '8', 'journal-title': 'Nanomedicine', 'key': '10.1016/j.ejpb.2024.114279_b0030', 'volume': '6', 'year': '2011'}, { 'DOI': '10.1016/j.compbiomed.2021.105149', 'article-title': 'In vitro and computational insights revealing the potential inhibitory ' 'effect of Tanshinone IIA against influenza A virus', 'author': 'Elebeedy', 'doi-asserted-by': 'crossref', 'journal-title': 'Comput. Biol. Med.', 'key': '10.1016/j.ejpb.2024.114279_b0035', 'volume': '141', 'year': '2022'}, { 'DOI': '10.2174/156720108784911695', 'article-title': 'Self-nanoemulsifying drug delivery system for enhanced bioavailability ' 'and improved hepatoprotective activity of biphenyl dimethyl ' 'dicarboxylate', 'author': 'El-Laithy', 'doi-asserted-by': 'crossref', 'first-page': '170', 'issue': '3', 'journal-title': 'Curr. Drug Deliv.', 'key': '10.1016/j.ejpb.2024.114279_b0040', 'volume': '5', 'year': '2008'}, { 'DOI': '10.1016/j.ijpharm.2015.05.039', 'article-title': 'Novel self-nanoemulsifying self-nanosuspension (SNESNS) for enhancing ' 'oral bioavailability of diacerein: Simultaneous portal blood absorption ' 'and lymphatic delivery', 'author': 'El-Laithy', 'doi-asserted-by': 'crossref', 'first-page': '146', 'issue': '1–2', 'journal-title': 'Int. J. Pharm.', 'key': '10.1016/j.ejpb.2024.114279_b0045', 'volume': '490', 'year': '2015'}, { 'DOI': '10.1021/acsomega.1c05519', 'article-title': 'In silico and in vitro studies for benzimidazole anthelmintics ' 'repurposing as VEGFR-2 antagonists: novel mebendazole-loaded mixed ' 'micelles with enhanced dissolution and anticancer activity', 'author': 'Elmaaty', 'doi-asserted-by': 'crossref', 'first-page': '875', 'issue': '1', 'journal-title': 'ACS Omega', 'key': '10.1016/j.ejpb.2024.114279_b0050', 'volume': '7', 'year': '2021'}, { 'DOI': '10.1080/20786204.2012.10874190', 'article-title': 'Sprays and lozenges for sore throats', 'author': 'Farrer', 'doi-asserted-by': 'crossref', 'first-page': '26', 'issue': '2', 'journal-title': 'S. Afr. Fam. Pract.', 'key': '10.1016/j.ejpb.2024.114279_b0055', 'volume': '54', 'year': '2012'}, { 'DOI': '10.1007/s40005-021-00544-w', 'article-title': 'Nanoparticles of ZnO/Berberine complex contract COVID-19 and ' 'respiratory co-bacterial infection in addition to elimination of ' 'hydroxychloroquine toxicity', 'author': 'Ghareeb', 'doi-asserted-by': 'crossref', 'first-page': '735', 'journal-title': 'J. Pharm. Investig.', 'key': '10.1016/j.ejpb.2024.114279_b0060', 'volume': '51', 'year': '2021'}, { 'DOI': '10.18433/jpps32705', 'article-title': 'Recent advances in oral mucoadhesive drug delivery', 'author': 'Golshani', 'doi-asserted-by': 'crossref', 'first-page': '201', 'journal-title': 'J. Pharm. Pharm. Sci.', 'key': '10.1016/j.ejpb.2024.114279_b0065', 'volume': '25', 'year': '2022'}, { 'DOI': '10.3390/pharmaceutics10030110', 'article-title': 'Useful in vitro techniques to evaluate the mucoadhesive properties of ' 'hyaluronic acid-based ocular delivery systems', 'author': 'Graça', 'doi-asserted-by': 'crossref', 'first-page': '110', 'issue': '3', 'journal-title': 'Pharmaceutics', 'key': '10.1016/j.ejpb.2024.114279_b0070', 'volume': '10', 'year': '2018'}, { 'DOI': '10.1208/s12248-012-9432-8', 'article-title': 'Therapeutic roles of curcumin: lessons learned from clinical trials', 'author': 'Gupta', 'doi-asserted-by': 'crossref', 'first-page': '195', 'issue': '1', 'journal-title': 'AAPS J', 'key': '10.1016/j.ejpb.2024.114279_b0075', 'volume': '15', 'year': '2013'}, { 'DOI': '10.1023/A:1015812615635', 'article-title': 'A simple rheological method for the in vitro assessment of ' 'mucin-polymer bioadhesive bond strength', 'author': 'Hassan', 'doi-asserted-by': 'crossref', 'first-page': '491', 'journal-title': 'Pharm. Res.', 'key': '10.1016/j.ejpb.2024.114279_b0080', 'volume': '7', 'year': '1990'}, { 'key': '10.1016/j.ejpb.2024.114279_b0085', 'unstructured': 'Inc, C. (2016). Molecular operating environment (MOE). . Chemical ' 'Computing Group Inc, 1010.'}, { 'DOI': '10.1007/s13205-014-0214-0', 'article-title': 'Nanoemulsion: an advanced mode of drug delivery system', 'author': 'Jaiswal', 'doi-asserted-by': 'crossref', 'first-page': '123', 'journal-title': '3 Biotech', 'key': '10.1016/j.ejpb.2024.114279_b0090', 'volume': '5', 'year': '2015'}, { 'DOI': '10.1080/14756366.2019.1690480', 'article-title': 'Inhibition of SARS-CoV 3CL protease by flavonoids', 'author': 'Jo', 'doi-asserted-by': 'crossref', 'first-page': '145', 'issue': '1', 'journal-title': 'J Enzyme Inhib Med Chem.', 'key': '10.1016/j.ejpb.2024.114279_b0095', 'volume': '35', 'year': '2020'}, { 'DOI': '10.3390/nano13030574', 'article-title': 'Nanoparticles: Taking a unique position in medicine', 'author': 'Joseph', 'doi-asserted-by': 'crossref', 'first-page': '574', 'issue': '3', 'journal-title': 'Nanomaterials', 'key': '10.1016/j.ejpb.2024.114279_b0100', 'volume': '13', 'year': '2023'}, { 'DOI': '10.1002/iid3.479', 'article-title': 'A novel anti-inflammatory treatment for bradykinin-induced sore throat ' 'or pharyngitis', 'author': 'Leyva-Grado', 'doi-asserted-by': 'crossref', 'first-page': '1321', 'issue': '4', 'journal-title': 'Immun. Inflammation Dis.', 'key': '10.1016/j.ejpb.2024.114279_b0105', 'volume': '9', 'year': '2021'}, { 'DOI': '10.1016/j.sjbs.2018.11.018', 'article-title': 'Anti-inflammatory effect and the effect on acute pharyngitis rats model ' 'of compound Lobelia oral liquid', 'author': 'Liu', 'doi-asserted-by': 'crossref', 'first-page': '577', 'issue': '3', 'journal-title': 'Saudi Journal of Biological Sciences', 'key': '10.1016/j.ejpb.2024.114279_b0110', 'volume': '26', 'year': '2019'}, { 'DOI': '10.1182/blood.V86.7.2767.2767', 'article-title': 'Production of chemokines, interleukin-8 and monocyte chemoattractant ' 'protein-1, during monocyte: endothelial cell interactions1995', 'author': 'Lukacs', 'doi-asserted-by': 'crossref', 'first-page': '2767', 'issue': '7', 'journal-title': 'Blood', 'key': '10.1016/j.ejpb.2024.114279_b0115', 'volume': '86', 'year': '1995'}, { 'DOI': '10.1016/j.jddst.2021.102845', 'article-title': 'Delineating a potent antiviral activity of Cuphea ignea extract loaded ' 'nano-formulation against SARS-CoV-2: In silico and in vitro studies', 'author': 'Mahmoud', 'doi-asserted-by': 'crossref', 'journal-title': 'J. Drug Delivery Sci. Technol.', 'key': '10.1016/j.ejpb.2024.114279_b0120', 'volume': '66', 'year': '2021'}, { 'DOI': '10.3390/ijms22010385', 'article-title': 'Safe nanoparticles: are we there yet?', 'author': 'Najahi-Missaoui', 'doi-asserted-by': 'crossref', 'first-page': '385', 'issue': '1', 'journal-title': 'Int. J. Mol. Sci.', 'key': '10.1016/j.ejpb.2024.114279_b0125', 'volume': '22', 'year': '2020'}, { 'DOI': '10.1016/j.ijpharm.2010.10.045', 'article-title': 'Effect of process parameters on nanoemulsion droplet size and ' 'distribution in SPG membrane emulsification', 'author': 'Oh', 'doi-asserted-by': 'crossref', 'first-page': '191', 'issue': '1–2', 'journal-title': 'Int. J. Pharm.', 'key': '10.1016/j.ejpb.2024.114279_b0130', 'volume': '404', 'year': '2011'}, { 'DOI': '10.1186/s12951-018-0392-8', 'article-title': 'Nano based drug delivery systems: recent developments and future ' 'prospects', 'author': 'Patra', 'doi-asserted-by': 'crossref', 'first-page': '1', 'issue': '1', 'journal-title': 'J. Nanobiotechnol.', 'key': '10.1016/j.ejpb.2024.114279_b0135', 'volume': '16', 'year': '2018'}, { 'DOI': '10.1016/j.mehy.2020.110081', 'article-title': 'Surfactant-based prophylaxis and therapy against COVID-19: A ' 'possibility', 'author': 'Pramod', 'doi-asserted-by': 'crossref', 'journal-title': 'Med. Hypotheses', 'key': '10.1016/j.ejpb.2024.114279_b0140', 'volume': '143', 'year': '2020'}, { 'DOI': '10.3389/fphar.2021.675287', 'article-title': 'Curcumin as a Potential Treatment for COVID-19', 'author': 'Rattis', 'doi-asserted-by': 'crossref', 'first-page': '1068', 'journal-title': 'Front. Pharmacol.', 'key': '10.1016/j.ejpb.2024.114279_b0145', 'volume': '12', 'year': '2021'}, { 'DOI': '10.1016/j.bmc.2010.09.035', 'article-title': 'Biflavonoids from Torreya nucifera displaying SARS-CoV 3CL(pro) ' 'inhibition', 'author': 'Ryu', 'doi-asserted-by': 'crossref', 'first-page': '7940', 'issue': '22', 'journal-title': 'Bioorg Med Chem', 'key': '10.1016/j.ejpb.2024.114279_b0150', 'volume': '18', 'year': '2010'}, { 'DOI': '10.1007/s10787-023-01136-w', 'article-title': 'Curcumin and chemokines: mechanism of action and therapeutic potential ' 'in inflammatory diseases', 'author': 'Sadeghi', 'doi-asserted-by': 'crossref', 'first-page': '1069', 'issue': '3', 'journal-title': 'Inflammopharmacology', 'key': '10.1016/j.ejpb.2024.114279_b0155', 'volume': '31', 'year': '2023'}, { 'DOI': '10.1080/10717544.2022.2083724', 'article-title': 'Self-emulsifying drug delivery systems: a novel approach to deliver ' 'drugs', 'author': 'Salawi', 'doi-asserted-by': 'crossref', 'first-page': '1811', 'issue': '1', 'journal-title': 'Drug Deliv.', 'key': '10.1016/j.ejpb.2024.114279_b0160', 'volume': '29', 'year': '2022'}, { 'DOI': '10.1124/mol.61.3.554', 'article-title': 'Caffeic acid phenethyl ester and curcumin: a novel class of heme ' 'oxygenase-1 inducers', 'author': 'Scapagnini', 'doi-asserted-by': 'crossref', 'first-page': '554', 'issue': '3', 'journal-title': 'Mol Pharmacol', 'key': '10.1016/j.ejpb.2024.114279_b0165', 'volume': '61', 'year': '2002'}, { 'DOI': '10.1021/la010359g', 'article-title': 'Effect of didodecyldimethylammonium bromide on the phase behavior of ' 'nonionic surfactant− silicone oil microemulsions', 'author': 'Silas', 'doi-asserted-by': 'crossref', 'first-page': '4534', 'issue': '15', 'journal-title': 'Langmuir', 'key': '10.1016/j.ejpb.2024.114279_b0170', 'volume': '17', 'year': '2001'}, { 'DOI': '10.1016/j.puhe.2020.05.055', 'article-title': 'Possible beneficial role of throat gargling in the coronavirus disease ' 'pandemic', 'author': 'Tsai', 'doi-asserted-by': 'crossref', 'first-page': '45', 'journal-title': 'Public Health', 'key': '10.1016/j.ejpb.2024.114279_b0175', 'volume': '185', 'year': '2020'}, { 'article-title': 'Nitric oxide inhibits the release of TNF-α and IL-6 by down-regulating ' 'the expression of connexin 40 (Cx40) in rat T lymphocytes', 'author': 'Zhang', 'first-page': '385', 'issue': '5', 'journal-title': 'Journal of Cellular and Molecular Immunology', 'key': '10.1016/j.ejpb.2024.114279_b0180', 'volume': '34', 'year': '2018'}], 'reference-count': 36, 'references-count': 36, 'relation': {}, 'resource': {'primary': {'URL': ''}}, 'score': 1, 'short-title': [], 'source': 'Crossref', 'subject': ['Pharmaceutical Science', 'General Medicine', 'Biotechnology'], 'subtitle': [], 'title': 'Throat spray formulated with virucidal Pharmaceutical excipients as an effective early ' 'prophylactic or treatment strategy against pharyngitis post-exposure to SARS CoV-2', 'type': 'journal-article', 'update-policy': ''}
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop